Interim Results FY21-22
January '22
Contents
01 Investment Case
02 What we do
03 3 Year Strategy
04 Financial Performance
05 Funding Growth
06 Golden KPIs
07 M&A
08 Market Overview
09 Summary
Interim Results FY21-22
Investment Case
$30bn+ market | Accelerating structural | Good revenue visibility, |
opportunity | growth drivers | high quality of earnings |
12 years of profitable | Organic growth | A growing team |
growth, strong cash | and M&A in a | of experts |
generation | fragmented market |
Interim Results FY21-22 | 3 |
What we do
Our Purpose | Our Products | |
To make complying with regulation easy, quick and cost effective | A suite of user-friendly, reliable and cost-effective software | |
QHSE | RCA | Collaboration |
Quality - Health - Safety - Environment | Risk - Compliance - Audit | Regulated Collaboration |
250 hospitals | 300+ Aviation | 9 of the top 10 | 7 of the top global | 15 of the top 20 | ||||
in the UK and US | organisations globally | accounting firms | aerospace defence companies | pharma companies | ||||
Select
Clients
Interim Results FY21-22 | 4 |
Become a global leader in Governance, Risk & Compliance software. At the heart of conscious organisations, contributing where it matters.
Organic Growth
- Focus on new customer acquisition in core geographies and vertical markets
- Improve upsell to existing customer portfolio through improved product integration
M&A Strategy
- Adjacent capabilities and geographical expansion
- Maintain M&A discipline
- Value, Growth, Culture
- Actively integrate in to core pillars
Interim Results FY21-22 | 5 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ideagen plc published this content on 13 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2022 13:00:03 UTC.